# ContinuumOS

> A portfolio case study for an AI-assisted healthcare workflow that helps teams track diagnostic results, clinician review, referrals and next-step confirmation—while keeping clinical decisions human-controlled.

## Overview

ContinuumOS is a hypothetical care-orchestration overlay for the diagnostic-closure workflow: the period between a diagnostic result becoming available and the next human-confirmed care step.

The case explores how authorised clinic, diagnostic and receiving-team users could see verified context, workflow state, ownership, blockers, handoff evidence and audit history without replacing the source EHR.

All patient, encounter and workflow data in this repository is synthetic.

## First-adopter boundary

The long-term context is accountable continuity across an integrated Indian care network. The first credible adoption context is narrower: **one diagnostic-closure pathway within one provider network**, initially spanning clinic, diagnostics and receiving-team coordination. Hospital-wide operations, discharge and home recovery remain roadmap context, not MVP scope.

## The problem addressed

A result being available does not prove that it has been clinically reviewed, has an accountable owner or has been converted into a safe next step. ContinuumOS defines a bounded workflow to make those gaps visible and recoverable.

**Portfolio framing:** Integrated Indian healthcare networks need more than connected data. When care moves between clinic, diagnostics, specialist, hospital and home-recovery settings, teams need accountable workflow continuity: a verified result, a human decision, a named owner, an accepted handoff where required and a confirmed next step. ContinuumOS is the in-house orchestration layer for that gap.

This hypothetical case is relevant to emerging integrated care networks in Pune and other Indian metros. It does not claim a relationship, deployment or integration with any named healthcare operator or technology vendor.

```text
Diagnostic result available
  → clinician review and acknowledgement
  → human follow-up direction
  → referral handoff or clinic-management work
  → receiving response where required
  → next step confirmed
  → scoped diagnostic-closure workflow completion
```

## Product principles

- Source systems remain authoritative; ContinuumOS is an overlay, not an EHR replacement.
- Clinical acknowledgement, follow-up direction, referral acceptance, financial authorisation and scoped closure remain human-controlled.
- Exceptions such as uncertain identity, incomplete results, duplicate events and unavailable clinicians stay visible until safely resolved.
- Audit history is attributable and append-oriented; corrections do not erase prior evidence.
- AI is optional and cannot be required for safe workflow progression.

## How the layers fit together

The detailed logical diagram and its evidence boundaries are in [the Sprint 4 architecture principles](Sprints/Sprint_4_Architecture_and_AI_Operating_Model/architecture_principles_and_boundary.md#integrated-care-network-positioning). In brief: a licensed enterprise data-integration capability may connect source systems; SMART on FHIR provides authorised application access; ContinuumOS manages the internal workflow layer. These are complementary layers, not one claimed vendor implementation.

## Controlled AI boundary

The case permits only two assistive AI capabilities:

1. A source-linked episode summary to help authorised users orient to verified context.
2. A post-approval referral-handoff draft to help prepare an operational package.

AI may not diagnose, determine urgency, match identity, acknowledge a result, choose a pathway, approve or send a referral, accept a referral, confirm a next step or close an episode. Every AI output is a reviewable draft with source references, uncertainty handling and a manual fallback.

## Prototype implementation boundary

Sprint 6 will build a real interactive frontend backed by project-controlled synthetic JSON, deterministic workflow logic, pre-written AI outputs and visible prototype audit evidence.

The prototype will not use a production backend, live hospital API, real AI/model call or source-system write-back. Its purpose is to demonstrate the approved workflow, human controls, failure handling and evidence trace—not production integration or model performance.

## What this case demonstrates

- Bounded problem selection, product strategy and explicit opportunity costs.
- Healthcare workflow, ownership and human decision-right design.
- Requirements, traceability, prioritisation and controlled change planning.
- Proportionate architecture and legacy/API integration judgement.
- Optional AI assistance with source linkage, human review and manual fallback.
- Safety, testing, release and validation planning with clear evidence limits.

## Repository structure

| Area | Contents |
|---|---|
| `00_Project_Charter/` | Accepted case boundary, objectives, constraints and evidence status. |
| `01_Day_1_Product_Framing/` | Product case, workflow model, tracer patient and decision baseline. |
| `Sprints/Sprint_2_Care_Journey_and_Operating_Model/` | Care journey, decision rights, source-of-record and failure paths. |
| `Sprints/Sprint_3_Users_Decisions_and_MVP/` | Users, jobs, MVP scope, field mapping and integration assumptions. |
| `Sprints/Sprint_4_Architecture_and_AI_Operating_Model/` | Logical architecture, simulated SMART/FHIR boundary, AI controls and audit model. |
| `Sprints/Sprint_5_Clickable_Prototype/` | Requirements baseline, traceability, planned screen specifications and low-fidelity wireframes. |
| `Sprints/Sprint_6_Prototype_Build_Testing_and_Controlled_Release/` | Pre-created build, testing, AI-evaluation, safety and release-control artifacts; execution has not started. |
| `Sprints/Sprint_7_External_Validation_Synthetic_Pilot_and_Portfolio_Packaging/` | Pre-created reviewer, pilot, evidence and interview-packaging structures; validation has not started. |

## Current status

Sprints 1–5 are complete. Sprint 5 is the approved requirements and solution baseline for ten prototype screens.

Sprint 6 is next but has **not started**. Sprint 6–7 plans, control artifacts and evidence templates were created in advance; they are not implementation, test, reviewer or pilot evidence. No clickable prototype, live integration, deployed model, user research, clinical validation or outcome claim is made.

Sprint 6 must build from the approved Sprint 5 baseline and use formal change control. See the [project status](STATUS.md) for the detailed evidence-readiness view.

## Key artifacts

- [Portfolio case-study summary](portfolio_case_study_summary.md)
- [Hospital-systems discovery context and problem coverage](hospital_systems_discovery_and_problem_coverage.md)
- [Business requirements baseline](Sprints/Sprint_5_Clickable_Prototype/brd_lite.md)
- [Prototype-readiness review and approved baseline](Sprints/Sprint_5_Clickable_Prototype/prototype_readiness_review_and_approval_baseline.md)
- [Screen specifications and low-fidelity wireframes](Sprints/Sprint_5_Clickable_Prototype/screen_specifications_and_wireframe_pack.md)
- [Requirements traceability matrix](Sprints/Sprint_5_Clickable_Prototype/requirements_traceability_matrix.csv)
- [Simplified architecture and prototype runtime](Sprints/Sprint_4_Architecture_and_AI_Operating_Model/simplified_architecture.md)
- [AI service cards and control matrix](Sprints/Sprint_4_Architecture_and_AI_Operating_Model/ai_service_cards_and_control_matrix.md)
- [Sprint 6 build and controlled-release plan](Sprints/Sprint_6_Prototype_Build_Testing_and_Controlled_Release/prototype_build_and_release_plan.md)
- [AI evaluation rubric and release thresholds](Sprints/Sprint_6_Prototype_Build_Testing_and_Controlled_Release/ai_evaluation_rubric_and_release_thresholds.md)
- [Product safety hazard-and-control register](Sprints/Sprint_6_Prototype_Build_Testing_and_Controlled_Release/product_safety_hazard_and_control_register.csv)
- [Sprint 7 interview presentation outline](Sprints/Sprint_7_External_Validation_Synthetic_Pilot_and_Portfolio_Packaging/interview_presentation_outline.md)
- [Project status](STATUS.md)

## Recommended interviewer reading path

Start with these six headline areas; the remaining controls provide supporting delivery evidence.

1. [Product case, selection rationale and strategy](portfolio_case_study_summary.md).
2. [Workflow, ownership and human decision model](Sprints/Sprint_2_Care_Journey_and_Operating_Model/care_episode_operating_model.md).
3. [Approved requirements and prototype-readiness baseline](Sprints/Sprint_5_Clickable_Prototype/prototype_readiness_review_and_approval_baseline.md).
4. [Architecture, interoperability and AI operating boundary](Sprints/Sprint_4_Architecture_and_AI_Operating_Model/architecture_principles_and_boundary.md).
5. [Wider hospital-system context and explicit coverage boundaries](hospital_systems_discovery_and_problem_coverage.md).
6. [Wireframes](Sprints/Sprint_5_Clickable_Prototype/screen_specifications_and_wireframe_pack.md), followed by clickable-prototype and validation evidence when Sprint 6–7 execution is completed.

## Scope note

This repository is an independent portfolio case study. It uses synthetic data only and is not production software, clinical advice, a clinical validation study or evidence of regulatory compliance.
